The Ministry of Health of the Russian Federation has developed a draft law on the introduction of mandatory ethical review for biotechnological medicinal products (BTMP), which will take effect on September 1, 2026. The document was published for public discussion on Wednesday.
According to the draft, a special committee will be created to assess the use of such drugs. BTMPs are made individually for each patient in a medical organization using their own cells or tissues. They are used to treat life-threatening diseases, including oncological, autoimmune, and cardiovascular diseases.
As indicated in the explanatory note, the purpose of the ethical review is to guarantee the safety and protection of patients' rights. The committee will assess the appropriateness of the drug's use, the patient's awareness of the risks and benefits, and the absence of conflicts of interest.
The initiative was prepared on the instructions of Deputy Prime Minister Tatyana Golikova. Currently, such drugs are used selectively, mainly in federal centers as part of scientific research or internal protocols.
Read more on the topic:
Rostec supplied 85 thousand units of equipment to medical institutions in the country
Now on home
Design engineers without experience are promised salaries from 80 thousand rubles
Hard and dense shot ensures the destruction of the target from the first hit, regardless of the drone's body material
Almost all body elements are zinc-treated
SOGAZ lost the case in court against UEC-UMPO
A rare SUV with a mileage of 38,533 km is offered for 2 million rubles
The government has included passenger and cargo airships among the key transport technologies of the future
Moscow sent 43 containers of weapons, including ATGMs and sniper rifles
There is a need to increase air traffic within Russia and abroad
Lada Niva Travel with a new 1.8-liter engine tested at temperatures of -25 and -30 °C
Производить первую энергию планировали ещё в апреле 2025 года
Retail is in second place, and education and medicine are in third place
The basic version of the system is capable of hitting targets at a range of up to 300 km